Developing Personalised Relative Physical Activity Thresholds in COPD.
NCT06330623
Summary
The aim of this observational study is to translate the principle of individualised exercise prescription into the evaluation of daily absolute and relative intensity physical activity. The main questions this study aims to answer are: * Phase 1: What does physical activity (intensity) mean to people with COPD? * Phase 2: Are there differences between time spent in absolute and relative physical activity for people with COPD? Phase 1 Participants will take part in semi-structured interview (30-45 minutes) about living with COPD and perceptions of physical activity and how they perceive intensity. This will also include photovoice and photo-elicitation. Demographic information will be recorded and participants will also complete several respiratory symptom questionnaires. Phase 2: Participants will take part in physical activity testing before and after pulmonary rehabilitation while wearing physical activity monitors. Demographic information will be recorded and participants will also complete several respiratory symptom and physical activity questionnaires. Participants will also wear the physical activity monitors for 8 days after the pre-testing sessions and after their final pulmonary rehabilitation class. Sub-study: Participants will be asked to take images of barriers during physical activity, facilitators during physical activity, feelings during physical activity and types of physical activity they take part in for 8 days after their final pulmonary rehabilitation class. Participants will then take part in a semi-structured interview about the images their have taken while doing physical activity.
Eligibility
Phase 1: Inclusion Criteria: * Willing and able to provide informed consent for participation in the research. * The patient has a confirmed diagnosis of COPD using spirometry (based on GOLD criteria (Agustí et al., 2023). * Male or female, aged 40+ years * Able to communicate in written and spoken English. Exclusion Criteria: * Unable to provide valid informed consent. * Severe psychiatric disorders * Aged less than 40 years * Unable to understand written or spoken English. Phase 2: Inclusion Criteria: * Willing and able to provide informed consent for participation in the research. * The patient has a confirmed diagnosis of COPD using spirometry (based on GOLD criteria. * The patient is referred for PR at the UHL. * Male or female, aged 40+ years * Able to communicate in written and spoken English Exclusion Criteria: * Unable to provide valid informed consent. * Lack of motivation to participate in PR programme. * Any-contra-indications absolute or relative to exercise training. * Has had a cardiac event within last 6 weeks * Severe psychiatric disorders * Patients with a history of MRSA +ve screens (patients can be assessed and given an exercise programme but cannot attend the classes. Patients need to have 3 consecutive -ve MRSA swabs before they can attend). * Aged less than 40 years * Unable to understand written or spoken English.
Conditions2
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06330623